Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Czechia

Coordination and Support Action · Ended early

ExcellPharmTech Center of Excellence in Advanced Pharmaceutical Technologies

Coordinator
Masarykova univerzita, Czechia
Runs
1 March 2023 to 29 February 2028
Status
Ended early
EU funding
€2.5m
Total cost
€2.5m
Partners
1 organisations in 1 countries
Type
Coordination and Support Action
Grant agreement
101086962

What the project is doing

In the project's own words, from its summary on CORDIS.

Masaryk University (MU) is the second-largest university in the Czech Republic located in Brno. Thanks to the ESIF funding, MU was able to acquire top research infrastructure attracting talented researchers who gradually built the position of the MU as the top regional hub for education, research, and innovation. To further exploit this potential, the management structures and processes of the university must thoroughly implement the European Research Area (ERA) Priorities.

As an outstanding researcher/innovator can have a decisive and positive impact on the culture and performance of any institution, MU will recruit a world-class research manager as an ERA Chair for its newly-established Faculty of Pharmacy. The Faculty of Pharmacy (MUNI Pharm) is, besides others, focused on the development of advanced drug formulations and molecular biology techniques. The ERA Chair will intensify the research and development of advanced drug formulation and nanotechnologies to open new opportunities to intensify MUNI Pharm research capacities in the field of pharmacy and develop strategic partnerships with the application sphere and public sector for faster translation of the advanced drugs into clinics.

The recruitment of leading scientist will enforce the connection of the MUNI Pharm to research structures of MU, and the ERA Chair will make a bridge in the formation of unique education and research facility at one place titled MUNI BioPharma Hub, supported from National Recovery Plan (part of RRF – Recovery and Resilience Facility, NextGeneration EU). To solve the targeted delivery and transportation of nucleic acids into target cell environment, the MUNI Pharm will establish an interdisciplinary center of excellence (Pharma Center of Excellence in Advanced Technology) with prof.

David Oupický as its leader. The creation of an international ERA Chair team will ensure a successful establishment of the center combining excellent research, high level education and top innovations.

Topics

Who is involved

OrganisationCityCountryRole
Masarykova univerzitaBrnoCzechiaCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI